The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anti-PD-1 for patients with leptomeningeal metastasis from advanced solid tumors: Efficacy, safety, and biomarkers of response.
 
Jarushka Naidoo
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Roche/Genentech
Research Funding - AstraZeneca (Inst); Merck (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Karisa C. Schreck
No Relationships to Disclose
 
Chen Hu
Consulting or Advisory Role - Merck Sharp & Dohme
 
Christopher Blair Douville
Stock and Other Ownership Interests - Thrive Global
Honoraria - Thrive Global
Consulting or Advisory Role - Thrive Global
Patents, Royalties, Other Intellectual Property - Thrive Global
 
Cesar Augusto Santa-Maria
Consulting or Advisory Role - Athenex; Bristol-Myers Squibb; Genomic Health; Halozyme; Polyphor
Research Funding - Medimmune; Pfizer; Pfizer; Tesaro (Inst)
 
Roisin M Connolly
Research Funding - Genentech (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); Puma Biotechnology (Inst)
 
Matthias Holdhoff
Consulting or Advisory Role - Abbvie; BTG; Celgene; DPClinical; DPClinical; Newlink Genetics
Travel, Accommodations, Expenses - Arbor Pharmaceuticals
 
Evan J. Lipson
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; EMD Serono; Macrogenics; Merck; Millennium; Novartis; Sanofi/Regeneron
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Regeneron (Inst); Sysmex (Inst)
Patents, Royalties, Other Intellectual Property - METHOD OF PREVENTING ORGAN TRANSPLANT REJECTIONS USING AGONISTS TO THE PD-1 CHECKPOINT PATHWAY (Inst)
 
Rose Parkinson
No Relationships to Disclose
 
Joanne Riemer
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Amanda Barnes
No Relationships to Disclose
 
Arun Venkatesan
No Relationships to Disclose
 
Chetan Bettegowda
No Relationships to Disclose
 
Stuart A. Grossman
Stock and Other Ownership Interests - Axxia Pharmaceuticals
Consulting or Advisory Role - Abbvie; Medicenna; Midatech Pharma
Patents, Royalties, Other Intellectual Property - Patent related to a subcutaneous polymeric opioid delivery system have been awarded.
 
Julie R. Brahmer
Honoraria - Roche/Genentech
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Genentech; Janssen Oncology; Lilly; Merck; Syndax
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Revolution; Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech
Other Relationship - Bristol-Myers Squibb; Janssen Oncology; merck